Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A modified cytotoxicity assay with high sensitivity.

U Keilholz1, R Dummer, H Welters

  • 1Medizinische Klinik und Poliklinik V, University of Heidelberg, FRG.

Scandinavian Journal of Clinical and Laboratory Investigation
|December 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Concordance of pathologic response assessment between local and central review in melanoma: a post hoc analysis of KEYMAKER-U02 substudy 02C.

ESMO open·2026
Same author

Five-year survival with tebentafusp in metastatic uveal melanoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same author

Uveal melanoma: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up.

ESMO open·2026
Same author

17.6% of patients in a German cohort with exocrine pancreatic cancer were diagnosed with a genetic tumor syndrome-a case for universal genetic testing?

ESMO gastrointestinal oncology·2026
Same author

Implementation and outcome of personalized treatment strategies in advanced genitourinary cancers.

ESMO open·2025
Same author

Efficacy of adjuvant therapy in patients with stage IIIA cutaneous melanoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same journal

Vitamin K-dependent proteins in patients undergoing head and neck free flap surgery - a prospective observational study.

Scandinavian journal of clinical and laboratory investigation·2026
Same journal

Challenges in the interpretation of amphetamine results: differences of reactivity between immunoassay and immunochromatography.

Scandinavian journal of clinical and laboratory investigation·2026
Same journal

Maternal whole blood mercury, cadmium and lead concentrations during pregnancy and lactation and infant heavy metal status at six months.

Scandinavian journal of clinical and laboratory investigation·2026
Same journal

Performance of Sysmex SP-50 automated slidemakers and stainers in three hematology laboratories.

Scandinavian journal of clinical and laboratory investigation·2026
Same journal

Digital misinformation and parental resistance to newborn heel-prick screening: an Instagram content analysis.

Scandinavian journal of clinical and laboratory investigation·2026
Same journal

Serum Krebs von den Lungen-6 and interstitial lung disease: a brief review.

Scandinavian journal of clinical and laboratory investigation·2026
See all related articles

A modified tritiated thymidine (3H-TdR) release assay offers enhanced sensitivity for measuring cytotoxic activity of lymphokine-activated killer (LAK) cells and peripheral blood lymphocytes (PBLs). This method improves upon the standard chromium release assay for immunotherapy monitoring.

Area of Science:

  • Immunology
  • Cellular Biology
  • Biotechnology

Background:

  • Adoptive immunotherapy utilizing lymphokine-activated killer (LAK) cells and interleukin-2 (IL-2) has increased the need for sensitive cytotoxicity assays.
  • The conventional 51chromium release assay suffers from limited sensitivity due to high, nonspecific background release.

Purpose of the Study:

  • To adapt the tritiated thymidine (3H-TdR) release assay for rapid assessment of cytotoxic activity in unstimulated peripheral blood lymphocytes (PBLs) and LAK cells.
  • To optimize assay conditions and validate its performance against the standard chromium release assay.

Main Methods:

  • Investigated the utility of 3H-thymidine (3H-TdR) release assay for evaluating rapid cytotoxic activity.
  • Determined optimal assay duration (24 h) and addressed interference from proliferating effector cells by adding cold thymidine (TdR).

Related Experiment Videos

  • Correlated results with the standard 51chromium release assay.

    • Main Results:

    • The 3H-TdR release assay demonstrated high sensitivity, overcoming limitations of the 51chromium release assay.
    • A 24-hour assay duration was found to be optimal, with cold TdR addition preventing false low results from effector cell proliferation.
    • The assay showed good correlation with the 51chromium release assay and revealed significant cytolysis of NK-resistant Daudi cells by unstimulated PBLs.

    Conclusions:

    • The modified 3H-TdR release assay is a sensitive and reliable method for assessing cytotoxic activity of PBLs and LAK cells.
    • This assay is well-suited for monitoring immunological responses in patients undergoing IL-2 and LAK cell-based immunotherapy.